Loading...
OTCM
BMCS
Market cap41kUSD
Jul 08, Last price  
0.00USD
1D
0.00%
Jan 2017
-75.00%
IPO
-98.18%
Name

BMCS Sumcoin Index Fund Inc

Chart & Performance

D1W1MN
OTCM:BMCS chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
Rev. gr., 5y
-72.48%
Revenues
0k
Net income
-3k
L-48.10%
-1,172,818-1,011,333-2,4250-61,400-109,670-322,560-115,146-5,624-2,919
CFO
-27k
L+60.36%
-1,169,0910-2,42500-29,618-182,033-16,774-26,898

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

BioTech Medics, Inc. operates as a holding company with a focus on the medical field. The firm manages therapeutic laser clinics that deliver treatment for diverse pain conditions impacting muscles, nerves, bones, and arthritic discomfort. Among its product offerings is SHBAN, an antiseptic sanitizing solution for hands and body. Additionally, the company develops and markets nutritional supplements, including BioBody Balance, a concentrated liquid vitamin, and BioBody Energy Spray, a natural, caffeine- and alcohol-free vitamin energy spray. These nutraceutical products are distributed via general retail channels. Founded in 1997 and headquartered in Southlake, Texas, BioTech Medics maintains laser pain centers across Texas, California, New Mexico, and Florida.
IPO date
Nov 13, 2002
Employees
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT